RELAPSING REMITTING MULTIPLE SCLEROSIS
Clinical trials for RELAPSING REMITTING MULTIPLE SCLEROSIS explained in plain language.
Never miss a new study
Get alerted when new RELAPSING REMITTING MULTIPLE SCLEROSIS trials appear
Sign up with your email to follow new studies for RELAPSING REMITTING MULTIPLE SCLEROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with MS: drug showdown aims to slow relapses
Disease control OngoingThis study compares two medications, ocrelizumab and fingolimod, in children and teens aged 10 to 17 with relapsing-remitting multiple sclerosis (MS). The goal is to see which drug better reduces the number of MS relapses and new brain lesions. Participants will receive one of th…
Matched conditions: RELAPSING REMITTING MULTIPLE SCLEROSIS
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated May 17, 2026 05:33 UTC
-
Could a simple blood test guide a better MS treatment?
Disease control OngoingThis study tests whether people with relapsing-remitting MS who have been stable for a year might do better by switching to the drug ofatumumab instead of staying on their current treatment. It also checks if a blood marker called neurofilament light (NfL) can predict who benefit…
Matched conditions: RELAPSING REMITTING MULTIPLE SCLEROSIS
Phase: PHASE4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 17, 2026 05:29 UTC
-
New immune therapy aims to tame multiple sclerosis Flare-Ups
Disease control OngoingThis study tests a new treatment that uses a patient's own immune cells (dendritic cells) to help control relapsing-remitting multiple sclerosis (MS). About 45 adults with MS will receive this cell therapy along with their usual MS medications. The goal is to see if the combinati…
Matched conditions: RELAPSING REMITTING MULTIPLE SCLEROSIS
Phase: PHASE2 • Sponsor: Judit Pich • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
MS study: could lifestyle changes replace drugs?
Disease control OngoingThis study looks at whether a healthy lifestyle—including diet, stress reduction, and exercise—can control symptoms and improve quality of life for people newly diagnosed with multiple sclerosis (MS) or its early stage, clinically isolated syndrome. Researchers are comparing two …
Matched conditions: RELAPSING REMITTING MULTIPLE SCLEROSIS
Phase: NA • Sponsor: Terry L. Wahls • Aim: Disease control
Last updated May 11, 2026 20:53 UTC
-
Diet and calorie cutting may ease MS symptoms, study says
Symptom relief OngoingThis study looks at whether eating a better diet and cutting calories can improve physical function, thinking, pain, fatigue, mood, and anxiety in 100 adults with multiple sclerosis. Participants are overweight or obese and have relapsing-remitting or secondary progressive MS. Re…
Matched conditions: RELAPSING REMITTING MULTIPLE SCLEROSIS
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Symptom relief
Last updated May 04, 2026 16:21 UTC